Private Capital Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Private Capital Group's BIIB Position: Q2 2022 in Review
Private Capital Group reduced its Biogen (BIIB) stake by 10% in Q2 2022, selling an estimated $1.23K and leaving 54 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #1014.
Private Capital Group first reported a position in BIIB in Q4 2017 and has held it in 19 quarters since. The position peaked at $211K in Q3 2018. 928 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.
- Private Capital Group held 54 shares of Biogen worth $11K as of Q2 2022.
- Private Capital Group sold 6 Biogen shares in Q2 2022, an estimated $1.23K.
- Biogen made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #1014 holding.
- Private Capital Group first reported a position in Biogen in Q4 2017 and has held it in 19 quarters since.
- Private Capital Group's Biogen position peaked at $211K in Q3 2018.
- 928 funds tracked by Wall St. Rank held Biogen as of Q2 2022.
Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.